Table 2.
Disease stage at diagnosis
| Disease stage | No. of patients (N = 47) |
|---|---|
| Clinicopathologic stage at diagnosis | |
| Mycosis fungoides | 12 |
| MF with large-cell transformation | 18 |
| Mycosis fungoides with Sézary syndrome | 9 |
| Mycosis fungoides with Sézary syndrome and | 8 |
| Large-cell transformation | 4 nodal; 1 tumor |
| Folliculotropic mycosis fungoides | 4 |
| TNMB stage at diagnosis | |
| IB–IIA Refractory IB | 2 |
| IIB Tumors (includes tumors with large-cell transformation) | 12 |
| IIIA Erythrodermic mycosis fungoides (<B2) | 1 |
| IVA Sézary syndrome (B2) and/or nodes | 18 |
| IVB Bone marrow positive, liver (n = 2) | 15 |
| TNMB maximum stage pretransplant | |
| IB–IIA Refractory IB | 4 |
| IIB Tumors (including large-cell transformation) | 8 |
| IIIA Erythrodermic mycosis fungoides (<B2) | 3 |
| IVA Sézary syndrome (B2) and/or nodes | 11 |
| IVB bone marrow positive, liver (n = 2) | 21 |
TNMB, tumor, node, blood, metastasis; MF, mycosis fungoides.